Recent 8-K filings for LFMD

• May 6, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01 ◈ Earnings Releases

  LifeMD Q1 revenue $50.2M beats guidance; adds 42k subscribers, record GLP-1 signups

  Revenue $50.2M vs guidance $48-49M; adj. EBITDA loss $4.5M in line.

• March 18, 2026, 7:59 PM ET leadership materiality 0.65 neutral item 5.02item 8.01item 9.01

  LifeMD appoints new CFO, promotes CBO and CMO; outgoing CFO to advise

  CFO Marc Benathen resigns effective March 31, 2026; will provide advisory services for 6–12 months at $38,117/month.

• March 9, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  LifeMD FY2025 rev $194.1M (+25%), adj EBITDA $15.3M (+309%); guides to >$250M run-rate by Q4 2026

  FY2025 revenue $194.1M (+25% YoY); adjusted EBITDA $15.3M (+309% YoY).

• January 6, 2026, 6:59 PM ET debt materiality 0.65 positive item 1.01item 2.03item 7.01item 9.01 ◈ Debt Financings◈ Material Agreements

  LifeMD closes $50M revolving credit facility with Citizens Bank, N.A.

  Facility provides $30M committed plus $20M accordion; maturity January 2, 2029.

• November 17, 2025, 6:59 PM ET earnings materiality 0.78 positive item 2.02item 9.01

  LifeMD Q3 revenue $60.2M (+13%), adj EBITDA $5.1M; paid off debt, sold WorkSimpli

  Total revenue $60.2M (+13% YoY); adjusted EBITDA $5.1M (+20% YoY).

• November 5, 2025, 6:59 PM ET other material materiality 0.65 negative item 7.01item 9.01

  LifeMD delays Q3 earnings, expects late 10-Q filing due to $4.6M revenue recognition corrections

  Q3 2025 earnings rescheduled to Nov 17, 2025; expects to file Form 12b-25 for late 10-Q.

• November 4, 2025, 6:59 PM ET M&A materiality 0.70 positive item 1.01item 2.01item 7.01item 9.01 ◈ M&A Transactions

  LifeMD sells majority stake in WorkSimpli for $65M enterprise value; receives $22M cash at close

  Sold 80% of WorkSimpli units to buyer group led by founder/CEO; enterprise value ~$65M.

• August 21, 2025, 7:59 PM ET other material materiality 0.70 negative item 4.01item 9.01 ◈ Auditor Changes ×2

  LifeMD dismisses CBIZ CPAs, appoints PwC; cites material weaknesses in internal controls

  On Aug 15, 2025, LifeMD dismissed CBIZ CPAs (appointed Apr 24, 2025) as auditor; no disagreements.

• August 5, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  LifeMD Q2 revenue up 23% to $62.2M, adjusted EBITDA up 223% to $7.1M; revises FY2025 guidance

  Total revenue $62.2M (+23% YoY), telehealth revenue $48.6M (+30%); telehealth adjusted EBITDA $3.4M (+560%).

• May 6, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  LifeMD Q1 revenue up 49% to $65.7M; first GAAP profit; raises FY 2025 guidance

  Total revenue $65.7M (+49% YoY); telehealth revenue up 70% to $55.8M.

• April 29, 2025, 7:59 PM ET M&A materiality 0.70 positive item 7.01item 9.01

  LifeMD acquires Optimal Human Health MD assets for 100k shares; launches women's health vertical

  Acquired key assets from Optimal Human Health MD for 100,000 shares of common stock (50k at close, 50k at 1yr) plus earn-out.

• March 10, 2025, 7:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  LifeMD Q4 revenue $64.3M (+43% YoY), adj EBITDA $9.0M; FY2025 rev guidance $265-275M

  Q4 2024 revenue $64.3M (+43% YoY); telehealth revenue $49.9M (+60%); GAAP net loss narrowed to $0.9M from $4.5M.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.80 · Median 0.65 · Most common event earnings

9 positive 2 negative 9 neutral

source · LFMD on sec.gov